Latest / Recovery News | Mental Health & Addiction Recovery
Measuring the Shifting Landscape of U.S. Drug Trials
When we look at modern medical science, the headlines are often dominated by the massive wave of weight loss and diabetes medications. But according to the May 2026 U.S. Clinical Trial Recruiting Pipeline Report released by Clinical Leader, these medications are rapidly evolving into a fascinating new tool for the addiction recovery world.
The report tracks two months of shifts in the clinical landscape, revealing that Eli Lilly's blockbuster compound tirzepatide—sold commercially as Mounjaro and Zepbound—is expanding its footprint at an incredible rate. Actively recruiting U.S. trials for…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.